Dr. Lili Cao is a partner at LIU SHEN & ASSOCIATES, specializing in the full-process management of patent portfolios, acquisition, and enforcement.

Dr. Lili Cao received her doctorate in pharmacy in 2005 and joined Liu Shen Law Firm the same year. Dr. Lili Cao has extensive experience managing the patent portfolios of large and medium-sized multinational companies in China and globally, enhancing patent value, and providing corporate intellectual property management and consulting services. She was recognized as a recommended individual in China for the "IAM Global Patent 1000" from 2022 to 2024.

Dr. Cao Lili has been deeply involved in the intellectual property field for two decades. Since representing a multinational pharmaceutical company in defending a pharmaceutical product patent in invalidation proceedings, administrative litigation, and retrial proceedings in 2007, she has handled numerous difficult cases. Representative cases include.

pound product patent (2009). This case was subsequently selected as a Guiding Case for Intellectual Property Trials by the Supreme People's Court (2011);

litigation of a gene editing patent. (2021-2024); this case was selected as one of the top ten patent reexamination and invalidation cases of 2024.